抗菌治疗。成本效益考量。 - Suppr

Suppr

超能文献

Antimicrobial therapy. Cost-benefit considerations.

作者信息

Guglielmo B J, Brooks G F

机构信息

Division of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco.

出版信息

Drugs. 1989 Oct;38(4):473-80. doi: 10.2165/00003495-198938040-00001.

DOI:10.2165/00003495-198938040-00001

PMID:2510985

Abstract

摘要

相似文献

Antimicrobial therapy. Cost-benefit considerations.抗菌治疗。成本效益考量。

Drugs. 1989 Oct;38(4):473-80. doi: 10.2165/00003495-198938040-00001.

Cost-effective antimicrobial therapy.

Am J Hosp Pharm. 1986 Mar;43(3):613-4.

How should we evaluate new anti-infectives for respiratory tract infections?

Can Respir J. 1999 Jan-Feb;6 Suppl A:31A-4A.

The cost of inappropriate use of anti-infective agents in older patients.老年患者不当使用抗感染药物的成本。

Drugs Aging. 1995 Apr;6(4):263-7. doi: 10.2165/00002512-199506040-00001.

[Silver coated urinary catheters. Clinical effectiveness and cost-benefit analysis].

Med Monatsschr Pharm. 2005 Oct;28(10):368-70.

Cost-effectiveness of imiquimod for anogenital warts.

Int J STD AIDS. 2002 Sep;13(9):647; author reply 647-8. doi: 10.1258/09564620260216371.

[Antibacterial therapy: pharmacoeconomic aspects].[抗菌治疗：药物经济学方面]

Antibiot Khimioter. 2002;47(9):24-30.

An open response to the technology scoping report examining the clinical and cost effectiveness of silver.

J Wound Care. 2013 Sep;22(9):514-9. doi: 10.12968/jowc.2013.22.9.514.

[Pharmacoeconomic evaluation of use of ciprofloxacin and norfloxacin with cost-benefit analysis].环丙沙星与诺氟沙星使用的药物经济学评价及成本效益分析

Med Arh. 2003;57(5-6):285-9.

Antimicrobial agents reports: specific considerations.

J Infect Dis. 1988 Oct;158(4):908-9. doi: 10.1093/infdis/158.4.908.

引用本文的文献

Antibiotic utilization pattern in a general medical ward of a tertiary medical center in Saudi Arabia.沙特阿拉伯一家三级医疗中心普通内科病房的抗生素使用模式。

Avicenna J Med. 2011 Jul;1(1):8-11. doi: 10.4103/2231-0770.83717.

Intravenous-to-oral conversion therapy for antimicrobials.抗菌药物的静脉给药至口服转换治疗

Can J Infect Dis. 1994 Jan;5(1):15-6. doi: 10.1155/1994/428375.

Hidden costs of antibiotics.

Pharmacoeconomics. 1996 Jul;10(1):99-100. doi: 10.2165/00019053-199610010-00010.

Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.替考拉宁：对其用于治疗革兰氏阳性菌感染的药物经济学评价

Pharmacoeconomics. 1995 Apr;7(4):357-74. doi: 10.2165/00019053-199507040-00009.

Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections.头孢曲松。对其用于治疗严重感染的药物经济学评价。

Pharmacoeconomics. 1994 Sep;6(3):249-69. doi: 10.2165/00019053-199406030-00009.

Imipenem/cilastatin: a pharmacoeconomic appraisal of its use in intra-abdominal infections.亚胺培南/西司他丁：对其用于腹腔内感染的药物经济学评估

Pharmacoeconomics. 1992 Jun;1(6):443-59. doi: 10.2165/00019053-199201060-00005.

Application of the ATC/DDD methodology to monitor antibiotic drug use.应用解剖治疗学分类系统/限定日剂量方法监测抗生素使用情况。

Eur J Clin Microbiol Infect Dis. 1998 Jan;17(1):20-4. doi: 10.1007/BF01584358.

Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.老年患者中氨基糖苷类药物的使用。药代动力学及临床考量。

Drugs Aging. 1997 Apr;10(4):259-77. doi: 10.2165/00002512-199710040-00003.

Antibiotic pharmacoeconomics: an attempt to find the real cost of hospital antibiotic prescribing.抗生素药物经济学：探寻医院抗生素处方真实成本的尝试。

Ulster Med J. 1993 Apr;62(1):50-7.

Computerised calculation of the true costs of antibiotic therapy.抗生素治疗真实成本的计算机化计算。

Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):622-5. doi: 10.1007/BF01973642.

本文引用的文献

Effectiveness of a cephalosporin education program--a pharmacy education program.一项头孢菌素教育计划——一项药学教育计划的成效

Drug Intell Clin Pharm. 1980 Apr;14(4):272-7. doi: 10.1177/106002808001400406.

Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis.

Ann Intern Med. 1980 Dec;93(6):832-4. doi: 10.7326/0003-4819-93-6-832.

Cost containment through restriction of cephalosporins.

Am J Hosp Pharm. 1981 Dec;38(12):1897-900.

Reduction in antibiotic costs by restricting use of an oral cephalosporin.通过限制口服头孢菌素的使用来降低抗生素成本。

Am J Med. 1981 Dec;71(6):941-4. doi: 10.1016/0002-9343(81)90304-1.

Improved antibiotic usage following introduction of a novel prescription system.引入新型处方系统后抗生素使用情况得到改善。

JAMA. 1981 Oct 16;246(16):1796-800.

The new beta-lactamase-stable cephalosporins.新型β-内酰胺酶稳定的头孢菌素。

Ann Intern Med. 1982 Sep;97(3):408-19. doi: 10.7326/0003-4819-97-3-408.

The use of an antibiotic order form for antibiotic utilization review: influence on physicians' prescribing patterns.

J Infect Dis. 1984 Dec;150(6):803-7. doi: 10.1093/infdis/150.6.803.

Cost containment associated with decreased parenteral antibiotic administration frequencies.与减少肠外抗生素给药频率相关的成本控制

Am J Med. 1984 Oct 19;77(4C):104-11.

Medical committee enforcement of policy limiting postsurgical antibiotic use.

Am J Hosp Pharm. 1984 Oct;41(10):2053-6.

Effect of aminoglycoside-use restrictions on drug cost.氨基糖苷类药物使用限制对药品成本的影响。

Am J Hosp Pharm. 1984 Jun;41(6):1137-9.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验